Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Cited In for PubMed (Select 8644848)


Expression of angiopoietin-TIE system components in angiosarcoma.

Buehler D, Rush P, Hasenstein JR, Rice SR, Hafez GR, Longley BJ, Kozak KR.

Mod Pathol. 2013 Aug;26(8):1032-40. doi: 10.1038/modpathol.2013.43. Epub 2013 Apr 5.


Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor.

Seif-Naraghi SB, Horn D, Schup-Magoffin PJ, Christman KL.

Acta Biomater. 2012 Oct;8(10):3695-703. doi: 10.1016/j.actbio.2012.06.030. Epub 2012 Jun 28.


Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.

Uldrick TS, Wyvill KM, Kumar P, O'Mahony D, Bernstein W, Aleman K, Polizzotto MN, Steinberg SM, Pittaluga S, Marshall V, Whitby D, Little RF, Yarchoan R.

J Clin Oncol. 2012 May 1;30(13):1476-83. doi: 10.1200/JCO.2011.39.6853. Epub 2012 Mar 19.


Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).

Ray-Coquard I, Italiano A, Bompas E, Le Cesne A, Robin YM, Chevreau C, Bay JO, Bousquet G, Piperno-Neumann S, Isambert N, Lemaitre L, Fournier C, Gauthier E, Collard O, Cupissol D, Clisant S, Blay JY, Penel N; French Sarcoma Group (GSF/GETO).

Oncologist. 2012;17(2):260-6. doi: 10.1634/theoncologist.2011-0237. Epub 2012 Jan 27.


Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma.

Jham BC, Ma T, Hu J, Chaisuparat R, Friedman ER, Pandolfi PP, Schneider A, Sodhi A, Montaner S.

PLoS One. 2011 Apr 29;6(4):e19103. doi: 10.1371/journal.pone.0019103.


Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Uldrick TS, Whitby D.

Cancer Lett. 2011 Jun 28;305(2):150-62. doi: 10.1016/j.canlet.2011.02.006. Epub 2011 Mar 4. Review.


Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy.

Nakashima T, Jinnin M, Etoh T, Fukushima S, Masuguchi S, Maruo K, Inoue Y, Ishihara T, Ihn H.

PLoS One. 2010 Dec 14;5(12):e14334. doi: 10.1371/journal.pone.0014334.


HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas.

Nyagol J, De Falco G, Lazzi S, Luzzi A, Cerino G, Shaheen S, Palummo N, Bellan C, Spina D, Leoncini L.

J Hematop. 2008 Jul;1(1):3-10. doi: 10.1007/s12308-008-0002-z. Epub 2008 Apr 16.


In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KM, Hilsher C, Gao SJ, Dittmer DP, Rafii S, Mesri EA.

Cancer Cell. 2007 Mar;11(3):245-58. Erratum in: Cancer Cell. 2007 May;11(5):471.


Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes.

Wilgus TA, Matthies AM, Radek KA, Dovi JV, Burns AL, Shankar R, DiPietro LA.

Am J Pathol. 2005 Nov;167(5):1257-66.


Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G.

J Clin Invest. 2002 Mar;109(6):777-85.


Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma.

Brown LF, Dezube BJ, Tognazzi K, Dvorak HF, Yancopoulos GD.

Am J Pathol. 2000 Jun;156(6):2179-83.


Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo.

Arbiser JL, Larsson H, Claesson-Welsh L, Bai X, LaMontagne K, Weiss SW, Soker S, Flynn E, Brown LF.

Am J Pathol. 2000 Apr;156(4):1469-76.


Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy.

Gerhardinger C, Brown LF, Roy S, Mizutani M, Zucker CL, Lorenzi M.

Am J Pathol. 1998 Jun;152(6):1453-62.


Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells.

Liu ZY, Ganju RK, Wang JF, Ona MA, Hatch WC, Zheng T, Avraham S, Gill P, Groopman JE.

J Clin Invest. 1997 Apr 1;99(7):1798-804.


Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas.

Berard M, Sordello S, Ortega N, Carrier JL, Peyri N, Wassef M, Bertrand N, Enjolras O, Drouet L, Plouet J.

Am J Pathol. 1997 Apr;150(4):1315-26.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk